Subscribe to the OSS Weekly Newsletter!

Leptin-A Hormone To Regulate Appetite?

8 Mar 2024

The implementation of glucagon-like peptide-1 (GLP-1)-based drugs for the treatment of obesity has been an incredible advance in the field, enabling up to 25% decreases in body weight in many...

What is next in the evolution of GLP-1-based therapies for diabetes and obesity?

15 Dec 2023

The first glucagon-like peptide-1 (GLP-1)-based therapeutic was approved by Health Canada in 2011 for the treatment of hyperglycemia in patients with Type 2 diabetes. Little was it suspected at...

Back to top